Thickening of the cell wall in macrolide-resistant Staphylococcus aureus

Medical Molecular Morphology

Volumn 46, Issue 4, 2013, Pages 217-224

  Hyo, Yukiyoshi ^a   Yamada, Sakuo ^a,b   Fukutsuji, Kenji ^a   Harada, Tamotsu ^a  

^a KAWASAKI MEDICAL SCHOOL   (Japan)

^b KAWASAKI UNIVERSITY OF MEDICAL WELFARE   (Japan)

Author keywords

Antibiotics resistance; Cell wall; Electron microscope; Macrolide; S. aureus

Indexed keywords

AMPICILLIN; ERYTHROMYCIN; HABEKACIN; LEVOFLOXACIN; MACROLIDE; OXACILLIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL WALL; BACTERIAL STRAIN; CELL ULTRASTRUCTURE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MORPHOLOGICAL TRAIT; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; THICKNESS; TRANSMISSION ELECTRON MICROSCOPY;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; CELL WALL; MACROLIDES; METHYLTRANSFERASES; MICROBIAL SENSITIVITY TESTS; MICROSCOPY, ELECTRON, TRANSMISSION; STAPHYLOCOCCUS AUREUS;

EID: 84891491661     PISSN: 18601480     EISSN: 18601499     Source Type: Journal    
DOI: 10.1007/s00795-013-0027-y     Document Type: Article

References (29)

1. Mölstad S, Erntell M, Hanberger H, Melander E, Norman C, Skoog G, Lundborg CS, Söderström A, Torell E, Cars O (2008) Sustained reduction of antibiotic use and low bacterial resistance: 10-year follow-up of the Swedish Strama programme. Lancet Infect Dis 8:125-132
2. Hatipoǧlu U, Rubinstein I (2008) Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm. Curr Allergy Asthma 8:154-161
3. Wada T, Sata M, Sato J, Tokairin Y, Machiya J, Hirama N, Arao T, Inoue S, Takabatake N, Shibata Y, Kubota I (2007) Clarithromycin suppresses invasiveness of human lung adenocarcinoma cells. Chemotherapy 53:77-84
4. Wallwork B, Coman W, Mackay-Sim A, Greiff L, Cervin A (2006) A double blind, randomized, placebo-controlled trial of macrolide in the treatment of chronic rhinosinusitis. Laryngoscope 116:189-193
5. Felmingham D (2007) Comparative antimicrobial susceptibility of respiratory tract pathogens. Chemotherapy 50(Suppl):3-10
6. Merino LA, Ronconi MC, Hreñuk GE, de Pepe MG (2003) Bacteriologic findings in patients with chronic sinusitis. Ear Nose Throat J 82:798-806
7. Hyo Y, Yamada S, Harada T (2008) Characteristic cell wall ultrastructure of a macrolide-resistant Staphylococcus capitis strain isolated from a patient with chronic sinusitis. Med Mol Morphol 41:160-164
8. Yamada S, Sugai M, Komatsuzawa H, Nakashima S, Oshida T, Matsumoto A, Suginaka H (1996) An autolysin ring associated with cell separation of Staphylococcus aureus. J Bacteriol 178:1565-1571
9. Nagayama A, Yamaguchi K, Watanabe K, Tanaka M, Kobayashi I, Nagasawa Z (2008) Final report from the Committee on Antimicrobial Susceptibility Testing, Japanese Society of Chemotherapy, on the agar dilution method. J Infect Chemother 14:383-392
10. Leclercq R (2002) Mechanisms of resistance to macrolides and lincosamides; nature of resistance elements and their clinical implication. Clin Infect Dis 34:482-492
11. Martineau F, Picard FJ, Lansac N, Ménard C, Roy PH, Ouellette M, Bergeron MG (2000) Correlation between the resistance genotype determined by multiplex PCR assays and the antibiotics susceptibility patterns of Staphylococcus aureus and Staphylococcus epidermidis. Antimicrob Agents Chemother 44:231-238
12. Janosi L, Nakajima Y, Hashimoto H (1990) Characterization of plasmids that confer inducible resistance to 14-membered macrolides and streptogramin type B antibiotics in Staphylococcus aureus. Microbiol Immunol 34:723-735
13. Sugai M, Yamada S, Nakashima S, Komatsuzawa H, Matsumoto A, Oshida T, Suginaka H (1997) Localized perforation of the cell wall by a major autolysin: atl gene products and the onset of penicillin-induced lysis of Staphylococcus aureus. J Bacteriol 179:2958-2962
14. Yamada S, Matsumoto A (1984) Localization of protein A on the cell surface of Staphylococcus aureus Cowan I and protein A-deficient strains. J Electron Microsc 33:172-174
15. Yamada S, Hyo Y, Ohmori S, Ohuchi M (2007) Role of ciprofloxacin in its synergistic effect with fosfomycin on drug-resistant strains of Pseudomonas aeruginosa. Chemotherapy 53:202-209
16. Hyo Y, Yamada S, Harada T (2012) Antimicrobial effects of Burow's solution on Staphylococcus aureus and Pseudomonas aeruginosa. Med Mol Morphol 45:66-71
17. Fukutsuji K, Yamada S, Harada T (2013) Ultrastructural cell wall characteristics of gentamycin-resistant Staphylococcus aureus isolate. Med Mol Morphol (in press)
18. Cui L, Ma X, Sato K, Okuma K, Tenover FC, Mamizuka EM, Gemmell CG, Kim MN, Ploy MC, El-Solh N, Ferraz V, Hiramatsu K (2003) Cell wall thickening is common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol 41:5-14
19. Palazzo IC, Araujo ML, Darini AL (2005) First report of vancomycin-resistant staphylococci isolated from healthy carriers in Brazil. J Clin Microbiol 43:179-185
20. Nishi H, Komatsuzawa H, Yamada S, Fujiwara T, Ohara M, Ohta K, Sugiyama M, Ishikawa T, Sugai M (2003) Moenomycin-resistance is associated with vancomycin-intermediate susceptibility in Staphylococcus aureus. Microbiol Immunol 47:927-935
21. Kawai M, Yamada S, Ishidoshiro A, Oyamada Y, Ito H, Yamagishi J (2009) Cell-wall thickness: possible mechanism of acriflavine resistance in methicillin-resistant Staphylococcus aureus. J Med Microbiol 58:331-336
22. Williams I, Paul F, Lloyd D, Jepras R, Critchley I, Newman M, Warrack J, Giokarini T, Hayes AJ, Randerson PF, Venables WA (1999) Flow cytometry and other techniques show that Staphylococcus aureus undergoes significant physiological changes in the early stages of surface-attached culture. Microbiology 145:1325-1333
23. Nishino T (1975) An electron microscopic study of antagonism between cephalexin and erythromycin in Staphylococcus aureus. Jpn J Microbiol 19:53-63
24. Cui L, Murakami H, Kuwahara-Arai K, Hanaki H, Hiramatsu K (2000) Contribution of a thickened cell wall and its glutamine nonamidated component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother 44:2276-2285
25. Hanaki H, Kuwahara-Arai K, Boyle-Vavra S, Daum RS, Labischinski H, Hiramatsu K (1998) Activated cell-wall synthesis is associated with vancomycin resistance in methicillin-resistant Staphylococcus aureus clinical strains Mu3 and Mu50. J Antimicrob Chemother 42:199-209
26. Pfeltz RF, Singh VK, Schmidt JL, Batten MA, Baranyk CS, Nadakavukaren MJ, Jayaswal RK, Wilkinson BJ (2000) Characterization of passage-selected vancomycin-resistant Staphylococcus aureus strains of diverse parental backgrounds. Antimicrob Agents Chemother 44:294-303
27. Sieradzki K, Tomasz A (2003) Alterations of cell wall structure and metabolism accompany reduced susceptibility to vancomycin in an isogenic series of clinical isolates of Staphylococcus aureus. J Bacteriol 185:7103-7110
28. Hanaki H, Labischinski H, Inaba Y, Kondo N, Murakami H, Hiramatsu K (1998) Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50. J Antimicrob Chemother 42:315-320
29. Chaieb K, Zmantar T, Chehab O, Bouchami O, Ben Hasen A, Mahdouani K, Bakhrouf A (2007) Antibiotic resistance genes detected by multiplex PCR assay in Staphylococcus epidermidis strains isolated from dialysis fluid and needles in a dialysis service. Jpn J Infect Dis 60:183-187